Suppr超能文献

糖尿病患者腰椎融合术的术前风险评估:基于数据驱动的糖化血红蛋白(HbA1c)和同日血糖水平分层预测90天并发症发生率

Preoperative Risk Assessment for Lumbar Fusion in Patients With Diabetes: Data-Driven Stratification of HbA1c and Same Day Glucose Levels that Predict 90-Day Complication Rates.

作者信息

Farnham Chloe, Liu Ivan Z, Agarwal Amil R, Parel Philip, Quan Theodore, Durand Wesley M, Raad Michael, Jain Amit

机构信息

Department of Orthopaedic Surgery, The Medical College of Georgia, Augusta, GA, USA.

Department of Orthopaedic Surgery, Johns Hopkins University, GA, USA.

出版信息

Global Spine J. 2025 Jan 20:21925682251315098. doi: 10.1177/21925682251315098.

Abstract

STUDY DESIGNS

Retrospective Database Analysis.

OBJECTIVES

Pre-operative glycemic control in diabetic patients undergoing lumbar fusion (LF) is essential for evaluating complication risk. However, current thresholds for preoperative HbA1c and same-day-glucose (SDG) are either non-specific or have low predictive power. This study uses HbA1c and SDG to provide data-driven risk stratification for 90-day major and wound complications in LF patients.

METHODS

Using a national database, patients undergoing LF from 2013-2022 with a recorded preoperative HbA1c and SDG level were included for analysis. Multiple HbA1c and SDG strata were identified using stratum specific likelihood ratio analysis (SSLR). Each stratum was then propensity-score matched to the lowest strata and compared using risk ratios. Significance level was set at a -value <0.05.

RESULTS

12,026 patients met inclusion criteria. For 90-day major complications, SSLR identified 3 predictive HbA1c (4.5-5.4, 5.5-7.9, and 8.0+) and SDG strata (60-159, 160-239, and 240+). Following propensity-matching, the 90-day major complication risk sequentially increased for HbA1c: 5.5-7.9 (1.69; = 0.001; 95% CI 1.24-2.30), 8.0+(2.31; < 0.001; 95% CI 1.56-3.43). Following propensity-matching, the SDG strata similarly demonstrated sequentially increasing 90-day major complication risk: 160-239 (1.34; < 0.001; 95% CI 1.18-1.54), 240+ (1.64; < 0.001; 95% CI 1.31-2.05). Matched analysis demonstrated a higher relative-risk of 90-day wound complications for the 8.0+ HbA1c strata (2.23; = 0.001; 95% CI 1.37-3.63) compared to the HbA1c 4.5-5.4 strata. No other strata were identified that predicted differences in 90-day wound complications.

CONCLUSIONS

This study identified data-driven HbA1c and SDG strata that better risk-stratify 90-day major complications following LF. Instead of current single-value thresholds, these multiple strata may be utilized for better preoperative guidance.

摘要

研究设计

回顾性数据库分析。

目的

对于接受腰椎融合术(LF)的糖尿病患者,术前血糖控制对于评估并发症风险至关重要。然而,目前术前糖化血红蛋白(HbA1c)和当日血糖(SDG)的阈值要么不具特异性,要么预测能力较低。本研究利用HbA1c和SDG为LF患者90天内的主要及伤口并发症提供数据驱动的风险分层。

方法

使用一个全国性数据库,纳入2013年至2022年期间接受LF且记录了术前HbA1c和SDG水平的患者进行分析。使用分层特定似然比分析(SSLR)确定多个HbA1c和SDG分层。然后将每个分层与最低分层进行倾向得分匹配,并使用风险比进行比较。显著性水平设定为P值<0.05。

结果

12026例患者符合纳入标准。对于90天主要并发症,SSLR确定了3个具有预测性的HbA1c分层(4.5 - 5.4、5.5 - 7.9和8.0+)和SDG分层(60 - 159、160 - 239和240+)。倾向匹配后,HbA1c分层90天主要并发症风险依次增加:5.5 - 7.9(1.69;P = 0.001;95%置信区间1.24 - 2.30),8.0+(2.31;P < 0.001;95%置信区间1.56 - 3.43)。倾向匹配后,SDG分层同样显示90天主要并发症风险依次增加:160 - 239(1.34;P < 0.001;95%置信区间1.18 - 1.54),240+(1.64;P < 0.001;95%置信区间1.31 - 2.05)。匹配分析表明,与HbA1c 4.5 - 5.4分层相比,HbA1c 8.0+分层90天伤口并发症的相对风险更高(2.23;P = 0.001;95%置信区间1.37 - 3.63)。未发现其他分层可预测90天伤口并发症的差异。

结论

本研究确定了数据驱动的HbA1c和SDG分层,能更好地对LF术后90天主要并发症进行风险分层。与当前的单一值阈值不同,这些多个分层可用于更好的术前指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4d6/12206967/cea71e6174cc/10.1177_21925682251315098-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验